A randomized, double-blind, placebo-controlled study to investigate the safety, tolerability, and pharmacokinetics of single enantiomer (+)-mefloquine compared with racemic mefloquine in healthy persons (Q34341756)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized, double-blind, placebo-controlled study to investigate the safety, tolerability, and pharmacokinetics of single enantiomer (+)-mefloquine compared with racemic mefloquine in healthy persons |
scientific article |
Statements
1 reference
A randomized, double-blind, placebo-controlled study to investigate the safety, tolerability, and pharmacokinetics of single enantiomer (+)-mefloquine compared with racemic mefloquine in healthy persons (English)
1 reference
Robert Tansley
1 reference
Julie Lotharius
1 reference
Anthony Priestley
1 reference
Fiona Bull
1 reference
Stephan Duparc
1 reference
Jörg Möhrle
1 reference
1 December 2010
1 reference
1 reference
83
1 reference
6
1 reference
1195-1201
1 reference
Identifiers
1 reference
1 reference
1 reference